![The Advanced Genomics Collaboration](https://cdn.prod.website-files.com/660b5eff79708432fc9b756c/661385a617a050a60dc42250_Innovation_Project_Image-03.webp)
Innovation Projects
![GenI-AIRSPACE: Genomically Informed Active Surveillance in Intermediate Risk Prostate Cancer](https://cdn.prod.website-files.com/6610b644af744c9cbab880c0/6630781d1c19caa940611bb7_Niall%20Corcoran-v3_horizontal.webp)
GenI-AIRSPACE: Genomically Informed Active Surveillance in Intermediate Risk Prostate Cancer
Genomic testing and predictive disease modelling to guide therapy and reduce the burden of prostate cancer diagnosis.
![Improving women's health outcomes through genomics](https://cdn.prod.website-files.com/6610b644af744c9cbab880c0/663079ac038d55de3c013b74_team%20photo.webp)
Improving women's health outcomes through genomics
Next-generation sequencing to find new solutions for patients with common endometrial-related health problems.
![Ocular Genomics Hub](https://cdn.prod.website-files.com/6610b644af744c9cbab880c0/6630666ffcab59cdd9021fdb_Lauren%20Ayton%20and%20Ceecee%20Britten-Jones.webp)
Ocular Genomics Hub
Establishing a comprehensive patient dataset of inherited retinal diseases, providing information to drive new treatments and therapies for the most common cause of blindness.
![Developing a Cancer of Unknown Primary (CUP) test](https://cdn.prod.website-files.com/6610b644af744c9cbab880c0/663065e3fc96cd10cb5031aa_Richard%20Tothill%20and%20Sarah-Jane%20Dawson_3.webp)
Developing a Cancer of Unknown Primary (CUP) test
Developing a rapid multi-omic liquid biopsy blood test utilising whole genome sequencing to resolve the difficult diagnosis of cancer of unknown primary origin.
![Liquid Biopsy Project](https://cdn.prod.website-files.com/6610b644af744c9cbab880c0/6610bd3b5c692dffca26a997_Innovation_Project_Image-03.webp)
Liquid Biopsy Project
The University of Melbourne Centre for Cancer Research’s clinical genomics team received support from the TAGC Innovation Fund to pioneer a less invasive way to collect tumour information from a simple blood test by deciphering small amounts of cancer-specific mutations in the bloodstream known as circulating tumour DNA (or ctDNA).
![ID Predict](https://cdn.prod.website-files.com/6610b644af744c9cbab880c0/663ae18789e7b827c9f2d00b_Innovation_Project_Image-02.webp)
ID Predict
Researchers at the Doherty Institute, in collaboration with computational biologists at the Melbourne School of Engineering and the Walter & Eliza Hall Institute received a $2 million grant to better understand disease progression in patients with COVID-19.